MENU
CING
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cingulate (CING) Ownership - Who owns Cingulate?

Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety... Show more

Profile

Industry
N/A
Address
1901 West 47th Place
Phone
+1 913 942-2300
Employees
14
Web
https://www.cingulate.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
66.54M
P/E Ratio
0.02
Total Cash
25.89M
Projected Growth
N/A
Total Debt
7.43M
Revenue
N/A
Risk (Beta)
-1.35
Dividend Yield
N/A
Total Cash/Share
1.92
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
CING
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
1901 West 47th Place
Phone
+1 913 942-2300
Employees
14
Web
https://www.cingulate.com